Please click the link below to read the full article!
The National Heart Institute (IJN) has become the first centre in Malaysia and South East Asia to implant a new stenting device, 'Bioresorbable Vascular Scaffold' (BVS), to revolutionise the treatment of coronary artery disease.
The new technology has a prospect for positive therapeutic outcomes resulting from its unique ability to treat blocked vessel, potentially restore vessel functions and disappear within approximately two years after implantation.
Malaysia’s expertise in treatment of heart diseases is on par with many of the western countries. Its hospitals, including the well-known National Heart Institute in Kuala Lumpur, have the best that cardiology and cardiac surgery has to offer. Many, having undergone heart treatment in Malaysia in turn recommend our doctors and facilities to their family and friends. Malaysia Healthcare is proud to partner the National Heart Institute, a JCI and MSQH accredited facility.
New IJN device for coronary artery treatment